Lindbrook Capital’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $2.22K | Sell |
737
-263
| -26% | -$791 | ﹤0.01% | 2249 |
|
|
2024
Q4 | $2.56K | Hold |
1,000
| – | – | ﹤0.01% | 2228 |
|
|
2024
Q3 | $3.72K | Buy |
+1,000
| New | +$3.72K | ﹤0.01% | 2133 |
|
|
2023
Q1 | – | Sell |
-1,000
| Closed | -$5.07K | – | 2852 |
|
|
2022
Q4 | $5.07K | Buy |
+1,000
| New | +$5.07K | ﹤0.01% | 1818 |
|
|
2022
Q2 | – | Sell |
-1,000
| Closed | -$6K | – | 2618 |
|
|
2022
Q1 | $6K | Hold |
1,000
| – | – | ﹤0.01% | 1527 |
|
|
2021
Q4 | $6K | Hold |
1,000
| – | – | ﹤0.01% | 1442 |
|
|
2021
Q3 | $10K | Hold |
1,000
| – | – | ﹤0.01% | 988 |
|
|
2021
Q2 | $14K | Hold |
1,000
| – | – | ﹤0.01% | 913 |
|
|
2021
Q1 | $24K | Hold |
1,000
| – | – | 0.01% | 684 |
|
|
2020
Q4 | $13K | Hold |
1,000
| – | – | ﹤0.01% | 810 |
|
|
2020
Q3 | $7K | Hold |
1,000
| – | – | ﹤0.01% | 961 |
|
|
2020
Q2 | $12K | Buy |
+1,000
| New | +$12K | ﹤0.01% | 774 |
|